Two-Step Strategy for OGTT in GDM: Laboratory Investigations and Protocols

Gestational Diabetes Mellitus (GDM) is glucose intolerance first recognized during pregnancy and is associated with adverse maternal and fetal outcomes if undiagnosed or untreated. Accurate laboratory testing is essential for timely diagnosis and management. One widely accepted method, particularly in the United States under recommendations from bodies such as the American College of Obstetricians and Gynecologists (ACOG) and American Diabetes Association (ADA), is the two-step strategy for GDM diagnosis.

Overview of the Two-Step Strategy

The two-step strategy separates initial screening from confirmatory diagnostic testing to optimize lab resources and reduce unnecessary prolonged testing.

Step 1 — 50 g Glucose Challenge Test (GCT)

Performed non-fasting between 24 and 28 weeks’ gestation. OUP Academic
The patient ingests a 50 g oral glucose load.
Blood collection: Single venous plasma glucose sample at 1 hour post-glucose load. OUP Academic
Interpretation: If the 1-hour plasma glucose exceeds a screening threshold, proceed to Step 2.
- Common thresholds used in laboratories include ≥130, 135 or 140 mg/dL (7.2, 7.5, or 7.8 mmol/L) depending on local policy and population risk. OUP Academic+1

Laboratory Notes:

No fasting required for Step 1, making it suitable for outpatient screening. OUP Academic
Plasma glucose should be analyzed using a validated laboratory method (e.g., enzymatic hexokinase) to ensure accuracy.

Step 2 — 100 g Oral Glucose Tolerance Test (OGTT)

If the Step 1 result is above the chosen threshold, a fasting 100 g OGTT is performed on a separate day. OUP Academic

Pre-Analytic Considerations:

Patient should fast overnight (8–12 hours).
Avoid strenuous exercise and high-carbohydrate meals for at least 3 days prior.
Perform in the morning to minimize diurnal variation. NCBI

Procedure and Blood Sampling:

Collect baseline fasting plasma glucose.
Ingest 100 g glucose solution.
Collect venous plasma glucose at 1 hour, 2 hours, and 3 hours after ingestion. OUP Academic

Diagnostic Criteria: Carpenter-Coustan

In clinical laboratory reporting, GDM is diagnosed when two or more plasma glucose values meet or exceed established thresholds during the 100 g OGTT:

Time Point	Plasma Glucose Threshold (Carpenter-Coustan)
Fasting	≥ 95 mg/dL (5.3 mmol/L)
1 hour	≥ 180 mg/dL (10.0 mmol/L)
2 hour	≥ 155 mg/dL (8.6 mmol/L)
3 hour	≥ 140 mg/dL (7.8 mmol/L)
Diagnosis requires at least 2 values above thresholds. Dr.Oracle

Alternative Criteria:
Some laboratories reference National Diabetes Data Group (NDDG) thresholds, which are slightly higher than Carpenter-Coustan values — but Carpenter-Coustan remains more commonly used in clinical practice due to better correlation with adverse outcomes. Dr.Oracle

Key Laboratory Considerations

Choice of Threshold for Step 1

Selecting a lower screening cut-off (e.g., 130 mg/dL) increases sensitivity but raises the number of confirmatory OGTTs performed. OUP Academic+1
A higher cut-off (e.g., 140 mg/dL) reduces unnecessary OGTTs but may miss some GDM cases. OUP Academic

Analytical best practice: Ensure plasma glucose measurements are done in accordance with laboratory quality standards (e.g., internal QC and external proficiency testing) to minimize pre- and analytic variability.

Interpretation and Reporting

Laboratory Result Categorization

Step 1 Negative: Plasma glucose below the selected threshold suggests low probability of GDM — no further OGTT needed. OUP Academic
Step 1 Positive: Plasma glucose above threshold triggers scheduling of the 100 g OGTT. OUP Academic
Step 2 Results:
- Two or more values ≥ thresholds: Report GDM diagnosis.
- Less than two values ≥ thresholds: GDM not confirmed — routine care and possibly repeat screening if clinical suspicion remains.

Clinical Laboratory Report Components

Patient identifiers and gestational age.
Test performed (50 g GCT vs 100 g OGTT).
Glucose values at each time point.
Interpretation: Whether thresholds are met and whether GDM is diagnosed.
Recommendations: Indicate if additional testing or clinical evaluation is required.

Advantages of the Two-Step Strategy in Laboratory Practice

Efficient use of resources: Most patients will only require the initial 1-hr screening test.
Patient convenience: Non-fasting 50 g test is easier to administer and increases compliance.
Clear diagnostic thresholds: Laboratory measurements at defined time points improve diagnostic precision and reproducibility.

Limitations and Considerations

Requires two patient visits: Positive screening necessitates a fasting OGTT on a separate day.
Cut-off variation: Different practices may use different glucose thresholds in Step 1 testing, affecting sensitivity and specificity.
Laboratory error risk: Pre-analytic errors (e.g., delayed sample processing) can impact glucose results — strict adherence to protocol is essential.

Conclusion

The two-step OGTT strategy for diagnosing Gestational Diabetes Mellitus is a lab-centric, practical, and widely used approach that balances efficient screening with diagnostic accuracy:

Non-fasting 50 g glucose challenge test to screen at 24–28 weeks, followed by
Fasting 100 g oral glucose tolerance test with multiple timed plasma glucose measurements for definitive diagnosis in screen-positive women.

This protocol ensures rigorous laboratory investigation while minimizing the burden of testing on patients and laboratories. If you want, I can provide flowcharts or sample lab report templates based on this strategy.

Blog